BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17166182)

  • 21. Long-term evolution of eight Spanish patients with CDG type Ia: typical and atypical manifestations.
    Pérez-Dueñas B; García-Cazorla A; Pineda M; Poo P; Campistol J; Cusí V; Schollen E; Matthijs G; Grunewald S; Briones P; Pérez-Cerdá C; Artuch R; Vilaseca MA
    Eur J Paediatr Neurol; 2009 Sep; 13(5):444-51. PubMed ID: 18948042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Congenital disorders of glycosylation].
    Durand G; Dupré T; Vuillaumier-Barrot S; Seta N
    Ann Pharm Fr; 2003; 61(5):330-9. PubMed ID: 13130291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased biosynthesis of glycosphingolipids in congenital disorder of glycosylation Ia (CDG-Ia) fibroblasts.
    Sala G; Dupré T; Seta N; Codogno P; Ghidoni R
    Pediatr Res; 2002 Nov; 52(5):645-51. PubMed ID: 12409508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG).
    Schollen E; Martens K; Geuzens E; Matthijs G
    Eur J Hum Genet; 2002 Oct; 10(10):643-8. PubMed ID: 12357336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Scandinavian CDG-Ia patients: genotype/phenotype correlation and geographic origin of founder mutations.
    Erlandson A; Bjursell C; Stibler H; Kristiansson B; Wahlström J; Martinsson T
    Hum Genet; 2001 May; 108(5):359-67. PubMed ID: 11409861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDG type Ia and congenital cytomegalovirus infection: two coexisting conditions.
    Jamroz E; Adamek D; Paprocka J; Adamowicz M; Marszał E; Wevers RA
    J Child Neurol; 2009 Jan; 24(1):13-8. PubMed ID: 19168813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
    Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
    Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Analysis of Variants in the General Population Reveals That
    Citro V; Cimmaruta C; Monticelli M; Riccio G; Hay Mele B; Cubellis MV; Andreotti G
    Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30061496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prenatal diagnosis of congenital disorder of glycosylation type Ia (CDG-Ia) by cordocentesis and transferrin isoelectric focussing of serum of a 27-week fetus with non-immune hydrops.
    Edwards M; McKenzie F; O'callaghan S; Somerset D; Woodford P; Spilsbury J; Fietz M; Fletcher J
    Prenat Diagn; 2006 Oct; 26(10):985-8. PubMed ID: 16915591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and molecular features of congenital disorder of glycosylation in patients with type 1 sialotransferrin pattern and diverse ethnic origins.
    Enns GM; Steiner RD; Buist N; Cowan C; Leppig KA; McCracken MF; Westphal V; Freeze HH; O'brien JF; Jaeken J; Matthijs G; Behera S; Hudgins L
    J Pediatr; 2002 Nov; 141(5):695-700. PubMed ID: 12410200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression analysis revealing destabilizing mutations in phosphomannomutase 2 deficiency (PMM2-CDG): expression analysis of PMM2-CDG mutations.
    Vega AI; Pérez-Cerdá C; Abia D; Gámez A; Briones P; Artuch R; Desviat LR; Ugarte M; Pérez B
    J Inherit Metab Dis; 2011 Aug; 34(4):929-39. PubMed ID: 21541725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical, laboratory and molecular findings and long-term follow-up data in 96 French patients with PMM2-CDG (phosphomannomutase 2-congenital disorder of glycosylation) and review of the literature.
    Schiff M; Roda C; Monin ML; Arion A; Barth M; Bednarek N; Bidet M; Bloch C; Boddaert N; Borgel D; Brassier A; Brice A; Bruneel A; Buissonnière R; Chabrol B; Chevalier MC; Cormier-Daire V; De Barace C; De Maistre E; De Saint-Martin A; Dorison N; Drouin-Garraud V; Dupré T; Echenne B; Edery P; Feillet F; Fontan I; Francannet C; Labarthe F; Gitiaux C; Héron D; Hully M; Lamoureux S; Martin-Coignard D; Mignot C; Morin G; Pascreau T; Pincemaille O; Polak M; Roubertie A; Thauvin-Robinet C; Toutain A; Viot G; Vuillaumier-Barrot S; Seta N; De Lonlay P
    J Med Genet; 2017 Dec; 54(12):843-851. PubMed ID: 28954837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue distribution of the murine phosphomannomutases Pmm1 and Pmm2 during brain development.
    Cromphout K; Keldermans L; Snellinx A; Collet JF; Grünewald S; De Geest N; Sciot R; Vanschaftingen E; Jaeken J; Matthijs G; Hartmann D
    Eur J Neurosci; 2005 Aug; 22(4):991-6. PubMed ID: 16115222
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underdiagnosis of mild congenital disorders of glycosylation type Ia.
    Giurgea I; Michel A; Le Merrer M; Seta N; de Lonlay P
    Pediatr Neurol; 2005 Feb; 32(2):121-3. PubMed ID: 15664773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Congenital disorder of glycosylation type Ia (CDG Ia) - underdiagnosed entity?].
    Sätilä H; Kuusela AL; Pietilä K; Niinikoski H; Keskinen P
    Duodecim; 2016; 132(3):253-9. PubMed ID: 26951030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coli.
    Kjaergaard S; Skovby F; Schwartz M
    Eur J Hum Genet; 1999 Dec; 7(8):884-8. PubMed ID: 10602363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome).
    Matthijs G; Schollen E; Pardon E; Veiga-Da-Cunha M; Jaeken J; Cassiman JJ; Van Schaftingen E
    Nat Genet; 1997 May; 16(1):88-92. PubMed ID: 9140401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defect of N-glycosylation is not directly related to congenital disorder of glycosylation Ia fibroblast sensitivity to staurosporine-induced cell death.
    Lavieu G; Frénoy JP; Codogno P; Botti J
    Pediatr Res; 2005 Aug; 58(2):254-7. PubMed ID: 16085795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prenatal diagnosis of congenital disorders of glycosylation (CDG).
    Matthijs G; Schollen E; Van Schaftingen E
    Prenat Diagn; 2004 Feb; 24(2):114-6. PubMed ID: 14974118
    [No Abstract]   [Full Text] [Related]  

  • 40. Yeast Models of Phosphomannomutase 2 Deficiency, a Congenital Disorder of Glycosylation.
    Lao JP; DiPrimio N; Prangley M; Sam FS; Mast JD; Perlstein EO
    G3 (Bethesda); 2019 Feb; 9(2):413-423. PubMed ID: 30530630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.